Skip to main content

INSIGHTS AND PERSPECTIVES

  • Study: Beauty marketing gone social; marketing forays suggest untapped promise

    PARSIPPANY, N.J. — Beauty brands rapidly are moving ahead with their social and mobile strategies to allow viral campaigns and create new consumer relations opportunities. But there’s no cookie-cutter approach, and brands are experimenting with what approaches work best for their business, according to a new report by consulting and research firm Kline.

  • Pharmacy Advisor program proving that it fills gaps in care

    WHAT IT MEANS AND WHY IT'S IMPORTANT — The results of CVS Caremark’s study, which found that its Pharmacy Advisor program increased medication adherence rates and physician initiation of prescriptions, is important as it further underscores the benefits of the program, and those benefits are bound to becomes even greater as the retailer gears up for the next generation of the clinical program.

  • IBM: Mobile shopping doubles over holiday

    ARMONK, N.Y. — On Tuesday, IBM released its final benchmark announcement for the 2011 holiday season, detailing a continued strong performance for mobile, as well as an overall increase in online spending for December 2011.

    According to the report, the U.S. online retail sector delivered 7.5% growth in December 2011, compared with the same period last year. This followed a strong November where both Black Friday 2011 and Cyber Monday 2011 delivered double-digit growth over 2010.

    Other key findings of the IBM report included:

  • Harvard School survey asserts NRT ineffective in spite of body of evidence to the contrary

    BOSTON — Nicotine replacement therapies designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking-cessation counseling, according to a new survey by researchers at Harvard School of Public Health and the University of Massachusetts Boston posted in an advance online edition of Tobacco Control Monday.

  • Hospira enrolls first patient in biosimilar trial

    LAKE FOREST, Ill. — Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

    The company said the phase-3 trial of biosimilar EPO (erythropoietin) would compare its product with Amgen's Epogen in patients with kidney dysfunction who have anemia. The trial, which will enroll about 1,000 patients who already have taken Epogen, follows a phase-1 trial that ended last year, and results of the late-stage trial are expected next year.

  • Those at risk of developing Type 2 diabetes don't seek lifestyle counseling, research finds

    ALEXANDRIA, Va. — Many patients that are at risk of Type 2 diabetes don't believe they require lifestyle counseling to help them curb their chance of developing the disease, according to new research published in the journal Diabetes Care.

  • CVS Caremark study: Pharmacy Advisor improved diabetes Rx initiation, adherence rates

    WOONSOCKET, R.I. — A CVS Caremark study found that the company's integrated pharmacy-based program — Pharmacy Advisor — increased medication adherence rates and physician initiation of prescriptions for concomitant medications, improving care for diabetes patients and resulting in savings for health plans, the company announced on Monday.

  • Is a turnaround at Sears Holdings on the way?

    WHAT IT MEANS AND WHY IT'S IMPORTANT — One of the most enduring rules of business is that when customers stop coming through the door, then the time has come for a reinvention.

    Recent decisions by Sears Holdings indicate that despite its financial problems, it's not too late for a comeback. The hiring of Ron Boire to head merchandising could give it new direction, while the introduction of the Fitness Flagship store-within-a-store allows Sears to capitalize on an area in which it has long specialized while taking advantage of the growing interest in health and wellness.

X
This ad will auto-close in 10 seconds